Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Seville
Clinical trial register · Spain

Clinical Trials in Seville, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 188 Madrid 183 Seville 71 Málaga 66 Valencia 60
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca71 Hoffmann-La Roche48 Merck Sharp & Dohme LLC47 Janssen Research & Development, LLC40 Eli Lilly and Company37 Clear sponsor filter
Site location
Barcelona188 Madrid183 Seville71 Málaga66 Valencia60
All 103 locations
Target enrolment
to

Trials with a site in Seville

71 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
AstraZeneca
Phase 3
750
Badalona, Barcelona, El Palmar, Madrid, Salamanca, Santander, Seville
2026-08-25
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Barcelona, Jaén, Madrid, Murcia, Salamanca, Sanlúcar de Barrameda (Cádiz), Seville, Valencia
2026-08-24
Recruiting
AstraZeneca
Phase 3
915
L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Santander, Seville
2026-07-16
Recruiting
AstraZeneca
Phase 3
800
Barcelona, Figueres, Seville
2026-07-06
Recruiting
AstraZeneca
Phase 3
900
Barcelona, Ferrol, Lleida, Madrid, Majadahonda, Málaga, Santander, Seville
2026-07-06
Recruiting
AstraZeneca
Phase 3
750
Badalona, Barcelona, Madrid, Pamplona, Salamanca, Seville, Valencia
2026-06-26
Recruiting
AstraZeneca
Phase 3
245
Barcelona, Córdoba, Galdakao, Madrid, Sabadell, Santander, Seville, Valencia
2026-04-13
Recruiting
AstraZeneca
Phase 1/2
180
Barcelona, Logroño, Pozuelo de Alarcón, Seville
2026-03-17
Recruiting
AstraZeneca
Phase 2
230
Alicante, Badalona, Madrid, Majadahonda, Seville
2025-12-10
Recruiting
AstraZeneca
Phase 3
400
A Coruña, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Seville, Zaragoza
2025-10-31
Recruiting
AstraZeneca
Phase 3
100
A Coruña, Barcelona, Granada, Madrid, Seville, Valencia
2025-10-30
Recruiting
AstraZeneca
Phase 3
250
Barcelona, Madrid, Seville
2025-08-07
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
A Coruña, Barcelona, Córdoba, Reus, Seville
2025-06-10
Active, closed
AstraZeneca
Phase 3
3,103
A Coruña, Barcelona, Córdoba, Madrid, Santiago(A Coruña), Seville
2025-05-28
Recruiting
AstraZeneca
Phase 1
72
Mérida, Seville, Valladolid
2025-05-01
Recruiting
AstraZeneca
Phase 3
990
Barakaldo, Barcelona, Granada, Madrid, Málaga, Palma de Mallorca, Pamplona, Seville
2025-03-18
Recruiting
AstraZeneca
Phase 3
840
Badalona, Barcelona, Madrid, Ourense, Santander, Seville, Valencia
2025-03-01
Recruiting
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
NCT06651970Chronic Lymphocytic Leukaemia, Moderate to Severe Cardiac Impairment
DrugAcalabrutinib
AstraZeneca
Phase 4
60
Barcelona, Madrid, Seville
2025-02-04
Recruiting
AstraZeneca
Phase 3
1,160
Barcelona, Castellon, Las Palmas de Gran Canaria, Madrid, Majadahonda, Seville
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Barcelona, Las Palmas de Gran Canaria, Lleida, Madrid, Majadahonda, Seville
2024-11-18
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Barcelona, Seville
2024-08-28
Recruiting
AstraZeneca
Phase 3
3,850
A Coruña, Barcelona, Lugo, Madrid, Majadahonda, Seville, Valencia
2024-04-12
Active, closed
AstraZeneca
Phase 3
594
Barcelona, Madrid, Ourense, Santander, Seville
2024-03-04
Active, closed
AstraZeneca
Phase 3
1,902
Barcelona, Granada, Hospitalet deLlobregat, Madrid, Santiago de Compostela, Seville, Zaragoza
2023-11-14
Active, closed
AstraZeneca
Phase 3
1,835
Girona, L'Hospitalet de Llobregat, Lugo, Madrid, Majadahonda, Seville, Valencia
2023-11-07
Active, closed
AstraZeneca
Phase 3
142
Barcelona, Madrid, Pamplona, Seville
2023-08-16
Recruiting
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
NCT05999877Chronic Lymphocytic Leukemia
AstraZeneca
Observational
315
Almería, Córdoba, Granada, Jaén, Marbella, Málaga, Seville, Zaragoza
2023-07-11
Active, closed
AstraZeneca
Phase 2
188
Badalona, Barcelona, Bilbao, Granada, L'Hospitalet de Llobregat, Madrid, Seville, Valencia
2023-03-06
Active, closed
AstraZeneca
Phase 3
1,350
Las Palmas de Gran Canaria, Lugo, Madrid, Santander, Seville, Valencia, Zaragoza
2022-12-29
Active, closed
First in Human Study of AZD9592 in Solid Tumors
NCT05647122Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Neoplasms, Colorectal Neoplasms
DrugsAZD9592·Osimertinib·Leucovorin·Adrucil
AstraZeneca
Phase 1
190
Barcelona, Madrid, Seville
2022-12-21
Active, closed
AstraZeneca
Phase 3
368
Barcelona, Madrid, Pamplona, Seville, Tomelloso
2022-11-10
Recruiting
AstraZeneca
Phase 2
454
Barcelona, Córdoba, Madrid, Málaga, Pamplona, Seville
2022-09-06
Active, closed
AstraZeneca
Phase 3
53
Badalona, Santiago de Compostela, Seville
2022-07-01
Recruiting
AstraZeneca
Phase 1/2
695
A Coruña, Barcelona, Málaga, Pozuelo de Alarcón, Sant Cugat del Vallès, Seville
2022-06-24
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Barcelona, Madrid, Málaga, Santiago de Compostela, Seville
2022-05-23
Active, closed
AstraZeneca
Phase 3
644
Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Santiago de Compostela, Seville
2022-05-16
Active, closed
AstraZeneca
Phase 3
1,035
Barcelona, Córdoba, Lugo, Madrid, Málaga, Sabadell, Seville
2022-03-25
Active, closed
AstraZeneca
Phase 3
148
A Coruña, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Pamplona, Seville
2021-10-28
Active, closed
AstraZeneca
Phase 3
927
Barcelona, Madrid, Seville, Vigo
2021-10-25
Active, closed
AstraZeneca
Phase 3
732
A Coruña, Barcelona, Bilbao (Vizcaya), Huelva, L'Hospitalet de Llobregat, Madrid, Málaga, Seville
2021-10-18
Active, closed
AstraZeneca
Phase 3
712
Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Pamplona, Seville
2021-08-05
Active, closed
AstraZeneca
Phase 3
506
Barcelona, Bilbao (Vizcaya), Granada, Madrid, Salamanca, Santander, Santiago de Compostela-Coruña, Seville
2021-06-22
Active, closed
AstraZeneca
Phase 3
367
Barcelona, Madrid, Santiago de Compostela, Seville, Valencia
2021-06-08
Active, closed
AstraZeneca
Phase 3
1,157
Alicante, Barcelona, Madrid, Majadahonda, Seville
2021-04-26
Recruiting
AstraZeneca
Phase 1
304
Badalona, Madrid, Seville, Valencia
2021-03-09
Active, closed
AstraZeneca
Phase 2
31
Seville, Valencia
2021-02-23
Active, closed
AstraZeneca
Phase 1
155
A Coruña, Badalona, Barcelona, Madrid, Seville
2021-02-02
Active, closed
AstraZeneca
Phase 3
1,371
Barcelona, Jaén, Lleida, Madrid, Málaga, Pamplona, Santander, Seville
2021-01-28
Active, closed
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
NCT04639219Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
102
Barcelona, Madrid, Pamplona, Seville
2020-12-30
Active, closed
AstraZeneca
Phase 1/2
245
Barcelona, L'Hospitalet de Llobregat, Madrid, Seville
2020-12-28
Active, closed
AstraZeneca
Phase 3
957
Barcelona, Madrid, Málaga, Ourense, Santander, Seville, Valencia
2020-11-17
Active, closed
AstraZeneca
Phase 1/2
702
Barcelona, Madrid, Málaga, Pozuelo de Alarcón, Seville
2020-11-12
Active, closed
AstraZeneca
Phase 3
866
A Coruña, Barcelona, Córdoba, El Palmar, Madrid, San Sebastián, Seville, Valencia
2020-07-24
Active, closed
AstraZeneca
Phase 3
1,012
Badalona (Barcelona), Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Seville
2020-07-13
Active, closed
AstraZeneca
Phase 2
452
Barcelona, Madrid, Santander, Seville
2020-06-03
Active, closed
AstraZeneca
Phase 2
240
Barcelona, Madrid, Seville, Zaragoza
2020-04-22
Active, closed
AstraZeneca
Phase 2
247
A Coruña, Barcelona, Madrid, Seville
2019-06-25
Active, closed
AstraZeneca
Phase 3
923
Badalona, Barcelona, Hospitalet deLlobregat, Jaén, Madrid, Málaga, Seville, Valencia
2019-06-25
Active, closed
AstraZeneca
Phase 3
724
Badajoz, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, San Sebastián, Santiago de Compostela, Seville
2019-03-06
Active, closed
AstraZeneca
Phase 1
175
Barcelona, Madrid, Seville
2018-12-27
Active, closed
AstraZeneca
Phase 3
1,063
Badalona, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Santander, Seville
2018-11-16
Active, closed
AstraZeneca
Phase 3
895
Barcelona, Girona, Madrid, Málaga, Seville
2018-10-31
Active, closed
AstraZeneca
Phase 1
396
Barcelona, Madrid, Seville, Valencia
2018-10-11
Active, closed
AstraZeneca
Phase 3
730
Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Barcelona, Lugo, Madrid, Málaga, Santander, Seville
2018-09-27
Active, closed
AstraZeneca
Phase 3
216
Barcelona, Madrid, Málaga, San Sebastián, Seville, Valencia
2018-07-19
Active, closed
AstraZeneca
Phase 2
273
Barcelona, Cáceres, Madrid, Palma de Mallorca, San Sebastián, Sant Cugat del Vallès, Seville, Valencia
2018-03-07
Active, closed
AstraZeneca
Phase 2
528
Barcelona, Madrid, Seville
2017-12-18
Active, closed
AstraZeneca
Phase 3
1,126
Badajoz, Badalona, Barcelona, Elche(Alicante), Madrid, Pozuelo de Alarcón, Santiago de Compostela, Seville
2015-11-02
Active, closed
AstraZeneca
Phase 3
510
Barcelona, Madrid, Málaga, Seville, Vigo(Pontevedra), Zaragoza
2013-09-25
Active, closed
AstraZeneca
Phase 3
736
A Coruña, Madrid, Málaga, Oviedo, Salamanca, Seville
2005-02-13
Rows per page Showing 1–71 of 71
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/seville

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 71 of those studies with a site in Seville that also match the filters currently applied.

How many clinical trials are recruiting in Seville?

22 of the 71 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 48 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seville), 71 studies
PhaseStudiesRecruitingShare
Phase 3471466.2%
Phase 211215.5%
Phase 1628.5%
Phase 1/2425.6%
Observational212.8%
Phase 4111.4%

Most active sponsors

Lead sponsors with the most studies (Seville)
Lead sponsorStudiesRecruiting
AstraZeneca7122
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.